Literature DB >> 18221619

Is there a cardiomyopathy of obesity?

Theophilus Owan1, Sheldon E Litwin.   

Abstract

Obesity is associated with structural and functional changes in the heart. These changes may be precursors to more overt forms of cardiac dysfunction and heart failure. However, it is not known 1) whether cardiac hypertrophy in obese individuals results directly from increased adioposity or from the effects of comorbid conditions such as hypertension, diabetes, and sleep-disordered breathing and 2) whether functional changes (eg, mild reductions in systolic and diastolic function) in obese patients progress over time to the point where they cause heart failure, unless ischemic heart disease develops. Establishing a clear link between obesity and heart failure is complicated by the fact that obesity must be present for many decades before the risk of heart failure increases substantially. At present, there are no longitudinal studies of changes in cardiac size and function in humans with obesity. This article reviews data showing structural and functional changes in the heart in obesity and the evidence that these are or are not progressive over time. At present, we believe it is uncertain whether there is a true "cardiomyopathy of obesity."

Entities:  

Mesh:

Year:  2007        PMID: 18221619     DOI: 10.1007/s11897-007-0016-3

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  48 in total

1.  Comparison of left ventricular mass and function in obese versus nonobese women <40 years of age.

Authors:  L L Crisostomo; L M Araújo; E Câmara; C Carvalho; F A Silva; M Vieira; A Rabelo
Journal:  Am J Cardiol       Date:  1999-11-01       Impact factor: 2.778

2.  Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss.

Authors:  M A Alpert; B E Terry; M Mulekar; M V Cohen; C V Massey; T M Fan; H Panayiotou; V Mukerji
Journal:  Am J Cardiol       Date:  1997-09-15       Impact factor: 2.778

3.  Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study.

Authors:  Sandeep R Das; Mark H Drazner; Daniel L Dries; Gloria L Vega; Harold G Stanek; Shuaib M Abdullah; Russell M Canham; Anne K Chung; David Leonard; Frank H Wians; James A de Lemos
Journal:  Circulation       Date:  2005-10-04       Impact factor: 29.690

4.  Effect of weight loss on left ventricular diastolic filling in morbid obesity.

Authors:  M A Alpert; C R Lambert; B E Terry; M V Cohen; M Mulekar; C V Massey; M W Hashimi; H Panayiotou; V Mukerji
Journal:  Am J Cardiol       Date:  1995-12-01       Impact factor: 2.778

5.  Relationship between preclinical abnormalities of global and regional left ventricular function and insulin resistance in severe obesity: a Color Doppler Imaging Study.

Authors:  V Di Bello; F Santini; A Di Cori; A Pucci; C Palagi; M G Delle Donne; M Giannetti; E Talini; C Nardi; G Pedrizzetti; P Fierabracci; P Vitti; A Pinchera; A Balbarini
Journal:  Int J Obes (Lond)       Date:  2006-06       Impact factor: 5.095

6.  Body fat distribution and left ventricular morphology and function in obese females.

Authors:  J Wikstrand; P Pettersson; P Björntorp
Journal:  J Hypertens       Date:  1993-11       Impact factor: 4.844

7.  Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging.

Authors:  Linda R Peterson; Alan D Waggoner; Kenneth B Schechtman; Timothy Meyer; Robert J Gropler; Benico Barzilai; Víctor G Dávila-Román
Journal:  J Am Coll Cardiol       Date:  2004-04-21       Impact factor: 24.094

8.  Influence of excess fat on cardiac morphology and function: study in uncomplicated obesity.

Authors:  Gianluca Iacobellis; Maria Cristina Ribaudo; Gaetano Leto; Alessandra Zappaterreno; Elio Vecci; Umberto Di Mario; Frida Leonetti
Journal:  Obes Res       Date:  2002-08

9.  Cardiac hypertrophy in obstructive sleep apnea syndrome.

Authors:  A Noda; T Okada; F Yasuma; N Nakashima; M Yokota
Journal:  Chest       Date:  1995-06       Impact factor: 9.410

Review 10.  Cardiovascular adaptation to obesity and hypertension.

Authors:  C J Lavie; F H Messerli
Journal:  Chest       Date:  1986-08       Impact factor: 9.410

View more
  8 in total

Review 1.  Adaptive mechanisms to compensate for overnutrition-induced cardiovascular abnormalities.

Authors:  Lakshmi Pulakat; Vincent G DeMarco; Sivakumar Ardhanari; Anand Chockalingam; Rukhsana Gul; Adam Whaley-Connell; James R Sowers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-03       Impact factor: 3.619

Review 2.  Cardiovascular consequences of metabolic syndrome.

Authors:  Johnathan D Tune; Adam G Goodwill; Daniel J Sassoon; Kieren J Mather
Journal:  Transl Res       Date:  2017-01-09       Impact factor: 7.012

Review 3.  Obesity cardiomyopathy and systolic function: obesity is not independently associated with dilated cardiomyopathy.

Authors:  Muhammad Fahad Khan; Mohammad Reza Movahed
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

4.  Obesity related risk of sudden cardiac death in the atherosclerosis risk in communities study.

Authors:  Selcuk Adabag; Rachel R Huxley; Faye L Lopez; Lin Y Chen; Nona Sotoodehnia; David Siscovick; Rajat Deo; Suma Konety; Alvaro Alonso; Aaron R Folsom
Journal:  Heart       Date:  2014-11-19       Impact factor: 5.994

5.  Higher plasma leptin levels are associated with reduced left ventricular mass and left ventricular diastolic stiffness in black women: insights from the Genetic Epidemiology Network of Arteriopathy (GENOA) study.

Authors:  Daisuke Kamimura; Takeki Suzuki; Wanmei Wang; Matthew deShazo; John E Hall; Michael D Winniford; Iftikhar J Kullo; Thomas H Mosley; Kenneth R Butler; Michael E Hall
Journal:  Hypertens Res       Date:  2018-06-15       Impact factor: 3.872

Review 6.  Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications.

Authors:  Jun Ren; Ne N Wu; Shuyi Wang; James R Sowers; Yingmei Zhang
Journal:  Physiol Rev       Date:  2021-05-05       Impact factor: 37.312

Review 7.  Mitochondrial quality control in diabetic cardiomyopathy: from molecular mechanisms to therapeutic strategies.

Authors:  Chen Cai; Feng Wu; Jing He; Yaoyuan Zhang; Nengxian Shi; Xiaojie Peng; Qing Ou; Ziying Li; Xiaoqing Jiang; Jiankai Zhong; Ying Tan
Journal:  Int J Biol Sci       Date:  2022-08-15       Impact factor: 10.750

Review 8.  Molecular Mechanisms of Obesity-Linked Cardiac Dysfunction: An Up-Date on Current Knowledge.

Authors:  Jorge Gutiérrez-Cuevas; Ana Sandoval-Rodriguez; Alejandra Meza-Rios; Hugo Christian Monroy-Ramírez; Marina Galicia-Moreno; Jesús García-Bañuelos; Arturo Santos; Juan Armendariz-Borunda
Journal:  Cells       Date:  2021-03-12       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.